首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6475篇
  免费   487篇
  国内免费   222篇
耳鼻咽喉   65篇
儿科学   121篇
妇产科学   25篇
基础医学   526篇
口腔科学   8篇
临床医学   695篇
内科学   1614篇
皮肤病学   34篇
神经病学   250篇
特种医学   76篇
外科学   1168篇
综合类   789篇
预防医学   365篇
眼科学   49篇
药学   1131篇
  5篇
中国医学   174篇
肿瘤学   89篇
  2023年   104篇
  2022年   111篇
  2021年   254篇
  2020年   248篇
  2019年   233篇
  2018年   237篇
  2017年   217篇
  2016年   173篇
  2015年   242篇
  2014年   418篇
  2013年   546篇
  2012年   453篇
  2011年   464篇
  2010年   373篇
  2009年   339篇
  2008年   279篇
  2007年   309篇
  2006年   256篇
  2005年   207篇
  2004年   164篇
  2003年   192篇
  2002年   181篇
  2001年   141篇
  2000年   133篇
  1999年   103篇
  1998年   76篇
  1997年   97篇
  1996年   64篇
  1995年   64篇
  1994年   47篇
  1993年   54篇
  1992年   37篇
  1991年   23篇
  1990年   32篇
  1989年   35篇
  1988年   33篇
  1987年   31篇
  1986年   22篇
  1985年   25篇
  1984年   23篇
  1983年   14篇
  1982年   23篇
  1981年   21篇
  1980年   21篇
  1979年   11篇
  1978年   14篇
  1977年   10篇
  1976年   10篇
  1974年   7篇
  1973年   5篇
排序方式: 共有7184条查询结果,搜索用时 15 毫秒
1.
2.
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes.  相似文献   
3.
4.
5.
6.
7.
Iron deficiency anemia is often listed among potential adverse effects of gastric acid-suppressive medications, given that gastric acidity promotes intestinal absorption of nonheme iron. Additionally, the antacid calcium carbonate can inhibit iron absorption. However, there is little direct clinical evidence that proton-pump inhibitors, histamine-2 receptor antagonists, or calcium carbonate cause iron deficiency anemia. Most case reports have had substantial limitations (e.g., minimal follow-up and presence of other causes of iron deficiency), and retrospective cohort studies have lacked sufficient patient-specific detail to make strong causal inferences. We present 2 cases—both with detailed, prospective 10-year follow-up—in which combinations of proton-pump inhibitors, histamine-2 receptor antagonists and calcium carbonate were clearly associated with development of iron deficiency anemia. Overt iron-deficiency anemia is probably uncommon in patients who use acid-modifying medications and who have no other conditions that predispose to iron deficiency. Nevertheless, clinicians should be aware of this potential complication, given widespread use of these agents.  相似文献   
8.
9.
Diabetes is a complex, chronic metabolic disorder affecting approximately 9.3% of the adult population with the estimated number of adults with diabetes worldwide having more than tripled since 2000. This increase has largely been attributed to global urbanization and lifestyle changes. Diabetes affects 10–15% of the surgical population. These patients are frequently elderly, have complex medical co-morbidities and present for both high-risk elective and emergency surgery. This multisystem disease poses a significant challenge to both anaesthesia and surgery with patients with diabetes demonstrating higher morbidity and mortality rates compared to their non-diabetic counterparts. It is crucial that good glycaemic control is maintained throughout the perioperative period as this has been shown to correlate with positive patient outcomes. It is well-recognized that a co-ordinated, multidisciplinary approach aimed at optimizing every point in the patient pathway from GP referral to post-discharge care is required to obtain the best outcomes for the surgical patient with diabetes. The anaesthetist has a key role in the perioperative diabetes multidisciplinary team. Patients themselves are well experienced in manging their own diabetes and should be involved in doing so whenever possible.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号